KYMR – Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc.KYMR
$44.12Name : Kymera Therapeutics, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $2,873,076,736.00
EPSttm : -3.11
Kymera Therapeutics, Inc.
$44.12
3.48%$1.59Float Short %
14.26
Margin Of Safety %
Put/Call OI Ratio
0.32
EPS Next Q Diff
-0.11
EPS Last/This Y
-0.62
EPS This/Next Y
-0.4
Price
44.12
Target Price
60.84
Analyst Recom
1
Performance Q
46.09
Relative Volume
4.25
Beta
2.18
Ticker: KYMR
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-06-02 | KYMR | 43.12 | 0.50 | 1.35 | 2782 |
| 2025-06-03 | KYMR | 43.58 | 0.61 | 0.93 | 3249 |
| 2025-06-04 | KYMR | 44.28 | 0.64 | 4.00 | 3921 |
| 2025-06-05 | KYMR | 47.69 | 0.68 | 0.71 | 4044 |
| 2025-06-06 | KYMR | 47.52 | 0.68 | 0.46 | 4041 |
| 2025-06-09 | KYMR | 47.14 | 0.68 | 0.28 | 4059 |
| 2025-06-10 | KYMR | 48.36 | 0.70 | 0.63 | 4041 |
| 2025-06-11 | KYMR | 48.4 | 0.70 | 0.74 | 4040 |
| 2025-06-12 | KYMR | 47.25 | 0.71 | 999.99 | 4079 |
| 2025-06-13 | KYMR | 46.95 | 0.70 | 8.00 | 4078 |
| 2025-06-16 | KYMR | 46.77 | 0.70 | 4.00 | 4077 |
| 2025-06-17 | KYMR | 46.34 | 0.70 | 1.33 | 4067 |
| 2025-06-18 | KYMR | 46.42 | 0.70 | 0.60 | 4065 |
| 2025-06-20 | KYMR | 45.88 | 0.70 | 2.84 | 4062 |
| 2025-06-23 | KYMR | 46.26 | 0.70 | 2.84 | 4062 |
| 2025-06-24 | KYMR | 47.23 | 0.32 | 0.00 | 3000 |
| 2025-06-25 | KYMR | 46.41 | 0.32 | 8.00 | 3001 |
| 2025-06-26 | KYMR | 45.65 | 0.32 | 0.67 | 3005 |
| 2025-06-27 | KYMR | 44.1 | 0.32 | 0.78 | 3016 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-06-02 | KYMR | 43.07 | -49.4 | -194.5 | -3.63 |
| 2025-06-03 | KYMR | 43.58 | -48.2 | -41.1 | -3.60 |
| 2025-06-04 | KYMR | 44.29 | -48.2 | -42.9 | -3.60 |
| 2025-06-05 | KYMR | 47.66 | -48.2 | -62.4 | -3.60 |
| 2025-06-06 | KYMR | 47.55 | -48.2 | -37.0 | -3.60 |
| 2025-06-09 | KYMR | 47.16 | -48.2 | -34.6 | -3.60 |
| 2025-06-10 | KYMR | 48.59 | -48.2 | -47.4 | -3.60 |
| 2025-06-11 | KYMR | 48.37 | -48.2 | -36.2 | -3.60 |
| 2025-06-12 | KYMR | 47.29 | -48.2 | -30.6 | -3.60 |
| 2025-06-13 | KYMR | 46.93 | -48.2 | -35.3 | -3.60 |
| 2025-06-16 | KYMR | 46.90 | -48.2 | -37.4 | -3.60 |
| 2025-06-17 | KYMR | 46.34 | -48.2 | -34.4 | -3.60 |
| 2025-06-18 | KYMR | 46.44 | -48.2 | -38.4 | -3.60 |
| 2025-06-20 | KYMR | 45.87 | -48.2 | -33.9 | -3.60 |
| 2025-06-23 | KYMR | 46.30 | -48.2 | -40.8 | -3.60 |
| 2025-06-24 | KYMR | 47.15 | -48.2 | -43.7 | -3.60 |
| 2025-06-25 | KYMR | 46.43 | -48.2 | -32.9 | -3.60 |
| 2025-06-26 | KYMR | 45.71 | -48.2 | -32.8 | -3.60 |
| 2025-06-27 | KYMR | 44.12 | -48.2 | -26.6 | -3.60 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-06-02 | KYMR | -0.21 | 2.73 | 13.14 |
| 2025-06-03 | KYMR | -0.19 | 2.73 | 13.14 |
| 2025-06-04 | KYMR | -0.63 | 2.73 | 13.14 |
| 2025-06-05 | KYMR | -0.63 | 2.73 | 13.14 |
| 2025-06-06 | KYMR | -0.63 | 2.73 | 13.14 |
| 2025-06-09 | KYMR | -0.63 | 2.77 | 13.14 |
| 2025-06-10 | KYMR | -0.63 | 2.77 | 13.14 |
| 2025-06-11 | KYMR | -0.63 | 2.77 | 12.38 |
| 2025-06-12 | KYMR | -0.67 | 2.77 | 12.38 |
| 2025-06-13 | KYMR | -0.66 | 2.77 | 12.39 |
| 2025-06-16 | KYMR | -0.66 | 2.80 | 12.39 |
| 2025-06-17 | KYMR | -0.66 | 2.80 | 12.39 |
| 2025-06-18 | KYMR | -0.66 | 2.80 | 12.39 |
| 2025-06-20 | KYMR | -0.66 | 2.80 | 12.39 |
| 2025-06-23 | KYMR | -0.66 | 2.78 | 12.39 |
| 2025-06-24 | KYMR | -0.66 | 2.78 | 12.39 |
| 2025-06-25 | KYMR | -0.66 | 2.78 | 12.39 |
| 2025-06-26 | KYMR | -0.66 | 2.78 | 14.26 |
| 2025-06-27 | KYMR | -0.66 | 2.78 | 14.26 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-0.82
Avg. EPS Est. Current Quarter
-0.86
Avg. EPS Est. Next Quarter
-0.93
Insider Transactions
-0.66
Institutional Transactions
2.78
Beta
2.18
Average Sales Estimate Current Quarter
17
Average Sales Estimate Next Quarter
13
Fair Value
Quality Score
28
Growth Score
27
Sentiment Score
17
Actual DrawDown %
52
Max Drawdown 5-Year %
Target Price
60.84
P/E
Forward P/E
PEG
P/S
48.8
P/B
3.65
P/Free Cash Flow
EPS
-3.1
Average EPS Est. Cur. Y
-3.6
EPS Next Y. (Est.)
-4
Target Price Estimates Raised
2
Target Price Estimates Lowered
3
Profit Margin
-409.07
Relative Volume
4.25
Return on Equity vs Sector %
-54.5
Return on Equity vs Industry %
-36.7
EPS 1 7Days Diff
EPS 1 30Days Diff
0.03
EBIT Estimation
-26.6
Kymera Therapeutics, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 208
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
stock quote shares KYMR – Kymera Therapeutics, Inc. Stock Price stock today
news today KYMR – Kymera Therapeutics, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch KYMR – Kymera Therapeutics, Inc. yahoo finance google finance
stock history KYMR – Kymera Therapeutics, Inc. invest stock market
stock prices KYMR premarket after hours
ticker KYMR fair value insiders trading